35429976|t|The cytokines interleukin-6 and interferon-alpha induce distinct microglia phenotypes.
35429976|a|BACKGROUND: Elevated production of the cytokines interleukin (IL)-6 or interferon (IFN)-alpha in the central nervous system (CNS) is implicated in the pathogenesis of neurological diseases such as neuromyelitis optica spectrum disorders or cerebral interferonopathies, respectively. Transgenic mice with CNS-targeted chronic production of IL-6 (GFAP-IL6) or IFN-alpha (GFAP-IFN) recapitulate important clinical and pathological features of these human diseases. The activation of microglia is a prominent manifestation found both in the human diseases and in the transgenic mice, yet little is known about how this contributes to disease pathology. METHODS: Here, we used a combination of ex vivo and in situ techniques to characterize the molecular, cellular and transcriptomic phenotypes of microglia in GFAP-IL6 versus GFAP-IFN mice. In addition, a transcriptomic meta-analysis was performed to compare the microglia response from GFAP-IL6 and GFAP-IFN mice to the response of microglia in a range of neurodegenerative and neuroinflammatory disorders. RESULTS: We demonstrated that microglia show stimulus-specific responses to IL-6 versus IFN-alpha in the brain resulting in unique and extensive molecular and cellular adaptations. In GFAP-IL6 mice, microglia proliferated, had shortened, less branched processes and elicited transcriptomic and molecular changes associated with phagocytosis and lipid processing. In comparison, microglia in the brain of GFAP-IFN mice exhibited increased proliferation and apoptosis, had larger, hyper-ramified processes and showed transcriptomic and surface marker changes associated with antigen presentation and antiviral response. Further, a transcriptomic meta-analysis revealed that IL-6 and IFN-alpha both contribute to the formation of a core microglia response in animal models of neurodegenerative and neuroinflammatory disorders, such as Alzheimer's disease, tauopathy, multiple sclerosis and lipopolysaccharide-induced endotoxemia. CONCLUSIONS: Our findings demonstrate that microglia responses to IL-6 and IFN-alpha are highly stimulus-specific, wide-ranging and give rise to divergent phenotypes that modulate microglia responses in neuroinflammatory and neurodegenerative diseases.
35429976	14	27	interleukin-6	Gene	16193
35429976	32	48	interferon-alpha	Gene	111654
35429976	136	154	interleukin (IL)-6	Gene	3569
35429976	158	180	interferon (IFN)-alpha	Gene	111654
35429976	254	275	neurological diseases	Disease	MESH:D020271
35429976	284	323	neuromyelitis optica spectrum disorders	Disease	MESH:D009471
35429976	327	354	cerebral interferonopathies	Disease	MESH:D002547
35429976	381	385	mice	Species	10090
35429976	426	430	IL-6	Gene	16193
35429976	432	436	GFAP	Gene	14580
35429976	437	440	IL6	Gene	16193
35429976	445	454	IFN-alpha	Gene	111654
35429976	456	460	GFAP	Gene	14580
35429976	533	538	human	Species	9606
35429976	624	629	human	Species	9606
35429976	661	665	mice	Species	10090
35429976	893	897	GFAP	Gene	14580
35429976	898	901	IL6	Gene	16193
35429976	909	913	GFAP	Gene	14580
35429976	918	922	mice	Species	10090
35429976	1021	1025	GFAP	Gene	14580
35429976	1026	1029	IL6	Gene	16193
35429976	1034	1038	GFAP	Gene	14580
35429976	1043	1047	mice	Species	10090
35429976	1091	1140	neurodegenerative and neuroinflammatory disorders	Disease	MESH:D019636
35429976	1218	1222	IL-6	Gene	16193
35429976	1230	1239	IFN-alpha	Gene	111654
35429976	1326	1330	GFAP	Gene	14580
35429976	1331	1334	IL6	Gene	16193
35429976	1335	1339	mice	Species	10090
35429976	1487	1492	lipid	Chemical	MESH:D008055
35429976	1546	1550	GFAP	Gene	14580
35429976	1555	1559	mice	Species	10090
35429976	1814	1818	IL-6	Gene	16193
35429976	1823	1832	IFN-alpha	Gene	111654
35429976	1915	1964	neurodegenerative and neuroinflammatory disorders	Disease	MESH:D019636
35429976	1974	1993	Alzheimer's disease	Disease	MESH:D000544
35429976	1995	2004	tauopathy	Disease	MESH:D024801
35429976	2006	2024	multiple sclerosis	Disease	MESH:D009103
35429976	2029	2047	lipopolysaccharide	Chemical	MESH:D008070
35429976	2056	2067	endotoxemia	Disease	MESH:D019446
35429976	2135	2139	IL-6	Gene	16193
35429976	2144	2153	IFN-alpha	Gene	111654
35429976	2272	2289	neuroinflammatory	Disease	MESH:D000090862
35429976	2294	2320	neurodegenerative diseases	Disease	MESH:D019636
35429976	Association	MESH:D002547	111654
35429976	Association	MESH:D000090862	111654
35429976	Association	MESH:D024801	16193
35429976	Positive_Correlation	MESH:D008070	MESH:D019446
35429976	Association	MESH:D008070	16193
35429976	Association	MESH:D020271	3569
35429976	Association	MESH:D009103	16193
35429976	Association	MESH:D019446	16193
35429976	Association	MESH:D000544	16193
35429976	Association	MESH:D019446	111654
35429976	Association	MESH:D009471	111654
35429976	Association	MESH:D000544	111654
35429976	Association	MESH:D008070	MESH:D019636
35429976	Association	MESH:D024801	111654
35429976	Association	14580	16193
35429976	Association	MESH:D002547	3569
35429976	Association	MESH:D008070	111654
35429976	Association	MESH:D008055	16193
35429976	Association	MESH:D009103	111654
35429976	Association	MESH:D009471	3569
35429976	Association	MESH:D020271	111654

